Stay updated on Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.

Latest updates to the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page
- CheckyesterdayChange DetectedA notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedAn error page (403 Forbidden) now appears where the study record content used to be, with site chrome (header/footer) still visible. The change effectively removes access to the study details from the public page, replacing it with an error notice and basic navigation.SummaryDifference20%

- Check43 days agoChange DetectedThe page’s topics/related topics area no longer lists the condition Type 2 diabetes, related topics, or MedlinePlus Genetics. This alters how the study is categorized and linked to related resources.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now includes a MedlinePlus Genetics related topics entry for Type 2 diabetes, linking readers to additional background information.SummaryDifference0.2%

Stay in the know with updates to Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.